Latest posts tagged with #ccRCC on Bluesky
#GU26 #ASCO Recap:
💥David McDermott, MD, Chief, Medical Oncology shared LITESPARK‑024 Phase 1/2 results in previously treated advanced #ccRCC
🏆 Hedyeh Ebrahimi, MD eoRCC multi‑omics study- earned @conquercancer.bsky.social Merit Award
🔑McDermott presented ccRCC Phase 2 KEYNOTE-427 tumor DNA data
Promising news from #GU26: Research led by @drchoueiri.bsky.social shows that adding #belzutifan to pembrolizumab adjuvant therapy prevented #ccRCC recurrence in high-risk patients better than pembrolizumab alone.
Learn more: https://bit.ly/3OxZdIE
Breaking news for people whose #KidneyCancer was not controlled by immunotherapy: Research led by Dr. Robert Motzer at #GU26 shows that #belzutifan + lenvatinib slows #ccRCC growth longer than cabozantinib.
Learn more: https://bit.ly/4aUKJtW
EORTC has opened the first site for the #RENALUT study, launching a Phase II evaluation of [177Lu]Lu‑PSMA‑617 in metastatic clear cell renal cell carcinoma after progression on prior treatments. More sites across Europe will follow.
🔗Read more: www.eortc.org/blog/2026/02...
#ccRCC #CancerResearch
☃️ It’s a pleasure to share today’s article from FEBSJ #Highlights2025. A perfect read for the weekend.
📕 CLEC18A interacts with sulfated glycosaminoglycans and controls clear cell renal cell carcinoma progression
Discover the article ➡️ buff.ly/qUo9aTH
#ccRCC #glycosaminoglycan #proteoglycan
This #STTT study identified a panel of seven blood-based protein #Biomarkers associated with TGF-β signaling and #Hypoxia that accurately detects #ccRCC, demonstrating the potential of liquid biopsies in diagnosis and target identification.
#OpenAccess: doi.org/10.1038/s413...
We are pleased to present our manuscript on the annotation of clear cell Renal Cell Carcinoma #GWAS risk loci, recently published in @commsbio.nature.com
www.nature.com/articles/s42...
#ccRCC #cancer #genetics #genomics #KidneyCancer
📢 New publication alert!
EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential.
🔗 www.eortc.org/publications/
#EORTC #RENALUT #ccRCC
A small phase I trial led by @braunmdphd.bsky.social
studied a personalized vaccine for stage III/IV #kidneycancer
showed promise: at 40+ months, none of the 9 patients had recurrence + durable T-cell responses have continued.
cancertodaymag.org/fall-2025/ca...
@nature.com #ccRCC
SCI member Erinn Rankin & others show FTO, an RNA demethylase, drives glutamine reprogramming in #ccRCC, promoting growth. Inhibiting FTO disrupts metabolism, > DNA damage, and reduces survival, but pyrimidines/antioxidants rescue, highlighting FTO as a target. pubmed.ncbi.nlm.nih.gov/40532011/
Coffee with Chromies Is Back - Katie Coleman
@katiekickscancer.bsky.social
@kidney-cancer.bsky.social
oncodaily.com/positive/kat...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #KidneyCancer #ccRCC
Huge credit to André Figueiredo (PhD, Biochem
@laqv-requimte.bsky.social). Collaboration with @UPMC
fueling clinical impact.
📎 Full story: doi.org/10.1016/j.ta...
#Proteomics #ccRCC #pRCC #chRCC #Oncocytoma #CancerDiagnostics #PROTEOMICSNOVA
#Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise #chemotherapy and #immunotherapy onlinelibrary.wiley.com/doi/full/10....
#ccRCC #Cancer #tumor #Bioinformatics
Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer
👉 buff.ly/D1G30KS
@drmeredithirwin
#ccRCC #CancerModels #KidneyCancer
Inceptor Bio Takes a Major Step in Clinical Trials for Cancer Therapy with New Funding #United_States #Research_Triangle_Park #Inceptor_Bio #IB-T101 #ccRCC
